Skip to main content
P

Pulike Biological Engineering,Inc. — Investor Relations & Filings

Ticker · 603566 Shanghai Stock Exchange Manufacturing
Filings indexed 1,077 across all filing types
Latest filing 2025-10-30 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 603566

About Pulike Biological Engineering,Inc.

Pulike Biological Engineering, Inc. specializes in the research, development, and production of veterinary biological products and pharmaceutical preparations. The company focuses on animal disease prevention through the manufacture of high-end vaccines, diagnostic reagents, and veterinary medicines. Its product range primarily serves the swine and poultry sectors, featuring advanced biologicals such as genetically engineered vaccines and synthetic peptide products. Pulike maintains a strong emphasis on technological innovation, utilizing national-level research platforms to develop solutions for complex animal health challenges. The company’s core activities encompass the entire value chain from basic biotechnology research to the commercialization of veterinary health solutions, aiming to improve livestock productivity and biosecurity.

Recent filings

Filing Released Lang Actions
普莱柯关于召开2025年第三季度业绩说明会的公告
Regulatory Filings
2025-10-30 Chinese
普莱柯第五届监事会第十四次会议决议公告
Regulatory Filings
2025-10-30 Chinese
普莱柯信息披露事务管理制度
Regulatory Filings
2025-10-30 Chinese
普莱柯信息披露暂缓与豁免业务内部管理制度
Regulatory Filings
2025-10-30 Chinese
普莱柯关联交易管理制度
Regulatory Filings
2025-10-30 Chinese
普莱柯董事会战略委员会工作规则
Regulatory Filings
2025-10-30 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.